Our Focus

TP-03

TP-03 is a novel, topical ophthalmic drug that may offer a safe and effective treatment for patients with Demodex Blepharitis.  TP-03 specifically targets the mite nervous system to kill the mites, thereby treating the underlying cause of disease.

It has shown rapid, complete, and durable efficacy with no serious adverse events across four Phase 2 studies and almost 100 treated patients.  Patients report that the drop is comfortable with zero study discontinuations due to tolerability.  TP-03 is currently being developed in a multi-dose, preserved formulation and is expected to begin Phase 3 trials this year.